SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001140361-24-026296
Filing Date
2024-05-15
Accepted
2024-05-15 17:19:20
Documents
23
Period of Report
2024-05-15

Document Format Files

Seq Description Document Type Size
1 6-K ef20029020_6k.htm 6-K 11183
2 EXHIBIT 99.1 ef20029020_ex99-1.htm EX-99.1 43056
3 EXHIBIT 99.2 ef20029020_ex99-2.htm EX-99.2 1891261
4 EXHIBIT 99.3 ef20029020_ex99-3.htm EX-99.3 6267
5 EXHIBIT 99.4 ef20029020_ex99-4.htm EX-99.4 7148
6 EXHIBIT 99.5 ef20029020_ex99-5.htm EX-99.5 8030
7 EXHIBIT 99.6 ef20029020_ex99-6.htm EX-99.6 6741
8 ex99_5-01.jpg GRAPHIC 211844
9 ex99_5-02.jpg GRAPHIC 302798
10 ex99_6-01.jpg GRAPHIC 144319
11 ex99_6-02.jpg GRAPHIC 165738
12 image0.jpg GRAPHIC 34628
13 image00001.jpg GRAPHIC 2235
14 image00003.jpg GRAPHIC 2882
15 image00004.jpg GRAPHIC 1665
16 image00005.jpg GRAPHIC 1952
17 image00006.jpg GRAPHIC 40361
18 image00007.jpg GRAPHIC 1863
19 image00014.jpg GRAPHIC 124461
20 image00015.jpg GRAPHIC 94203
21 image00016.jpg GRAPHIC 120750
22 image00017.jpg GRAPHIC 76793
23 image00018.jpg GRAPHIC 2094
  Complete submission text file 0001140361-24-026296.txt   3806119
Mailing Address JOSHUA DAWSON HOUSE DAWSON STREET DUBLIN 2 L2 D02 RY95
Business Address JOSHUA DAWSON HOUSE DAWSON STREET DUBLIN 2 L2 D02 RY95 353 1 437 8334
GH Research PLC (Filer) CIK: 0001855129 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40530 | Film No.: 24952608
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)